Clinical trial

Pilot Study of PLX3397 in Patients With Advanced Castration-Resistant Prostate Cancer (CRPC)

NCT01499043

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2012-05-25

PhasePHASE2

Study timeline

Study start (actual)2012-05-25Date precision: day

Registry last updated2020-03-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

PLX3397DRUG

Sponsors & collaborators

Daiichi Sankyolead sponsor

Plexxikoncollaborator

Mapped research locations

New YorkNew York, United States1 BostonMassachusetts, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01499043 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.